Hunting uncertainties: <scp>JAK</scp> inhibitors and cancer risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hunting uncertainties: JAK inhibitors and cancer risk

Published:2024-02 Issue:2 Volume:27 Page:
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Lee Hsiu‐Ming¹^ORCID,Chi Huan‐Ting²,Wei James Cheng‐Chung³⁴⁵⁶^ORCID

Affiliation:

1. School of Medicine China Medical University Taichung Taiwan

2. Department of Emergency Medicine Taichung Veterans General Hospital Taichung Taiwan

3. Department of Allergy, Immunology & Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

4. Institute of Medicine Chung Shan Medical University Taichung Taiwan

5. Department of Nursing Chung Shan Medical University Taichung Taiwan

6. Graduate Institute of Integrated Medicine China Medical University Taichung Taiwan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.15070

Reference18 articles.

1. Oral surveillance and JAK inhibitor safety: the theory of relativity

2. Tofacitinib versus methotrexate as the first‐line disease‐modifying antirheumatic drugs in the treatment of rheumatoid arthritis: An open‐label randomized controlled trial

3. Safety and efficacy of pharmacological treatments for axial spondyloarthritis

4. Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis

5. Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP